Typewriter Launches with $56 Million for All-RNA Gene Insertion

Company: Typewriter Therapeutics · Round: $56 Million Series A · Lead Investors: AN Venture Partners, RA Capital Management · Platform: R2-Retrotransposon All-RNA Gene Insertion · Date: September 2, 2026 Summary Typewriter Therapeutics emerged from stealth with a $56 million Series A led by AN Venture…